Indeed, Galectin-3-binding protein (LGALS3BP), gelsolin (Gsn), and Spartin (Spg20), which are associated with a favorable clinical outcome in colorectal carcinoma are downregulated in APLN-expressing cells and upregulated in APLN-DM-expressing cells. This evidence concerns the gene LGALS3BP and colorectal carcinoma.